Vanguard Group
WINT

Vanguard Group’s Windtree Therapeutics WINT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-41,640
Closed -$14.7K 4445
2024
Q1
$14.7K Hold
41,640
﹤0.01% 4410
2023
Q4
$29.9K Hold
41,640
﹤0.01% 4416
2023
Q3
$39.5K Buy
+41,640
New +$39.5K ﹤0.01% 4439
2023
Q1
Sell
-168,233
Closed -$28.6K 4579
2022
Q4
$28.6K Sell
168,233
-287,730
-63% -$48.9K ﹤0.01% 4478
2022
Q3
$137K Sell
455,963
-127,890
-22% -$38.4K ﹤0.01% 4464
2022
Q2
$243K Buy
583,853
+32,579
+6% +$13.6K ﹤0.01% 4443
2022
Q1
$629K Sell
551,274
-119,207
-18% -$136K ﹤0.01% 4338
2021
Q4
$1.08M Hold
670,481
﹤0.01% 4250
2021
Q3
$1.38M Buy
670,481
+44,424
+7% +$91.5K ﹤0.01% 4168
2021
Q2
$1.43M Buy
626,057
+86,728
+16% +$199K ﹤0.01% 4067
2021
Q1
$1.32M Buy
539,329
+262,800
+95% +$644K ﹤0.01% 3950
2020
Q4
$1.42M Buy
276,529
+2,788
+1% +$14.3K ﹤0.01% 3743
2020
Q3
$1.51M Buy
+273,741
New +$1.51M ﹤0.01% 3565